2001
DOI: 10.1006/bbrc.2001.5653
|View full text |Cite
|
Sign up to set email alerts
|

In Vivo Localization of Gelatinases (MMP-2 and -9) by in Situ Zymography with a Selective Gelatinase Inhibitor

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
40
0
2

Year Published

2004
2004
2014
2014

Publication Types

Select...
9

Relationship

4
5

Authors

Journals

citations
Cited by 39 publications
(45 citation statements)
references
References 37 publications
3
40
0
2
Order By: Relevance
“…The CTT peptide has also been used to modify the natural tropism of adenovirus for a therapeutic gene delivery in a rabbit restenosis model (Turunen et al, 2002). In addition, CTT peptide has been used to localize gelatinase activity in tissue samples using in situ zymography (Pirilä et al, 2001), and to evaluate the contribution of gelatinases in various biological processes including vasoconstriction, epithelial-mesenchymal transition and hepatitis (Cheng and Lovett, 2003;Fernandez-Patron et al, 2000;Franzke et al, 2002).…”
Section: Synthetic Gelatinase Inhibitorsmentioning
confidence: 99%
“…The CTT peptide has also been used to modify the natural tropism of adenovirus for a therapeutic gene delivery in a rabbit restenosis model (Turunen et al, 2002). In addition, CTT peptide has been used to localize gelatinase activity in tissue samples using in situ zymography (Pirilä et al, 2001), and to evaluate the contribution of gelatinases in various biological processes including vasoconstriction, epithelial-mesenchymal transition and hepatitis (Cheng and Lovett, 2003;Fernandez-Patron et al, 2000;Franzke et al, 2002).…”
Section: Synthetic Gelatinase Inhibitorsmentioning
confidence: 99%
“…Immunohistological stainings were performed using standard procedures and antibodies as described previously (38). Paraffin-embedded tissue specimens were deparaffinized, and immunostainings for MMP-9 (R&D Systems, Minneapolis, MN), MMP-13 (Chemicon, Temecula, CA), MMP-25 (Sigma-Aldrich Co., St. Louis, MO), COX-1 (Santa Cruz Biotechnology, Santa Cruz, CA), COX-2 (Santa Cruz Biotechnology), myeloperoxidase (MPO) (HyCult Biotechnology, b.v., Uden, The Netherlands), laminin-332 (32), neutrophil elastase (NE; Calbiochem-Novabiochem, San Diego, CA), interleukin-1␤ (IL-1␤; R&D Systems), and tumor necrosis factor alpha (TNF-␣; R&D Systems) were performed as described previously (30).…”
Section: Animalsmentioning
confidence: 99%
“…The latter approach was taken, first using a newly developed specific peptide inhibitor of gelatinases (57,86). Cyclic CTTHWGFTLC (cyclic CTT) has some preference for inhibiting MMP-2 relative to MMP-9 and is 10-fold more potent than STTHWGFTLS (STT).…”
Section: And Citations Therein)mentioning
confidence: 99%